Encompass Health earnings were $621.0M for the trailing 12 months ending Jun 30, 2026, with 19.8% growth year over year. The latest EHC earnings report on Jun 30, 2026 announced Q2 2026 earnings of $153.9M, down 20.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EHC reported annual earnings of $566.2M, with 24.2% growth. The next EHC earnings date is Nov 4, 2026.
EHC past earnings growth
How has EHC's earnings growth performed historically?
What were Encompass Health's earnings last quarter?
On EHC's earnings call on Aug 5, 2026, Encompass Health (NYSE: EHC) reported Q2 2026 earnings per share (EPS) of $1.55, up 9.93% year over year. Total EHC earnings for the quarter were $153.90 million. In the same quarter last year, Encompass Health's earnings per share (EPS) was $1.41.
The next EHC earnings date is Nov 4, 2026. Add EHC to your watchlist to be reminded of Encompass Health's next earnings date.
Is Encompass Health profitable or losing money?
As of the last Encompass Health earnings report, Encompass Health is currently profitable. Encompass Health's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $621.00 million, a 18.81% increase year over year.
What was EHC's earnings growth in the past year?
As of Encompass Health's earnings date in Aug 5, 2026, Encompass Health's earnings has grown 19.85% year over year. This is 30.95 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 50.8%. EHC earnings in the past year totalled $621.00 million.
What are Encompass Health's earnings expectations?
The current EPS estimate for Encompass Health's earnings report in Nov 4, 2026 is $1.37.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.